What Analysts Are Saying About Johnson & Johnson Stock
Portfolio Pulse from Benzinga Insights
Analysts have mixed opinions on Johnson & Johnson (NYSE:JNJ) with a range of ratings from bullish to bearish. The average 12-month price target has slightly decreased to $193.94. The company shows strong net margins and asset management but faces challenges in revenue growth and return on equity.
October 10, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Johnson & Johnson has received mixed analyst ratings, with a slight decrease in the average price target to $193.94. The company shows strong net margins and asset management but faces challenges in revenue growth and return on equity.
The mixed analyst ratings and slight decrease in price target suggest a neutral short-term impact on JNJ's stock price. The company's strong net margins and asset management are positive, but challenges in revenue growth and ROE may offset these strengths.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100